1700. Posaconazole-Induced Excess Mineralocorticoid Syndrome with Hypertension, Hypokalemia, and Inhibition of 11-b-hydroxylase in Pediatric Patients

BACKGROUND: Posaconazole is a potent broad spectrum mould-active triazole that is increasingly used in children for treatment of aspergillosis, mucormycosis, and endemic mycoses. Although posaconazole has a favorable safety profile in pediatric patients, we recently observed an excess mineralocortic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tempe K, Batra, Jagmohan S, Chawla, Rachit, Quanquin, Natalie, Michalik, David E, Sharma, Kavita, Farkas-Skiles, Cristina, Patel, Bhavita, Casillas, Jacqueline, Patel, Ramesh, Chung, Jong, Kadapakkam, Meena, Okada, Maki, Walsh, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676965/
http://dx.doi.org/10.1093/ofid/ofad500.1533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676965/
http://dx.doi.org/10.1093/ofid/ofad500.1533

Ejemplares similares